Skip to main content

Table 3 Analysis of baseline factors associated with mortality

From: A retrospective cohort study of body mass index and survival in HIV infected patients with and without TB co-infection

Variable at ART initiation

Univariate

Multivariate

HR (95% CI)

P-value

aHR (95% CI)

P-value

BMI group, kg/m2 (ref: 18.5–24.99)

< 18.5

2.91 (1.6–5.32)

0.001

2.93 (1.51–5.7)

0.002

 

25–29.99

1.09 (0.51–2.35)

0.825

1.25 (0.51–3.09)

0.624

 

≥30

0.95 (0.33–2.73)

0.918

1.14 (0.32–4.04)

0.841

Age (per 5–year increase)

 

1.09 (0.95–1.25)

0.238

1.1 (0.94–1.29)

0.232

Gender (ref: female)

Male

1.85 (1.09–3.14)

0.023

1.42 (0.74–2.72)

0.290

CD4+ cell count (per 50 cells/mm3 increase)

 

0.87 (0.74–1.02)

0.091

0.92 (0.8–1.06)

0.262

WHO stage (ref: 1–3)

Stage 4

2.53 (1.45–4.44)

0.001

2.04 (1.07–3.89)

0.029

Tuberculosis (ref: No)

Yes

1.05 (0.62–1.78)

0.857

0.99 (0.54–1.81)

0.976

  1. aHR Adjusted hazard ratio